Danaher Co. (NYSE:DHR) Shares Sold by B. Riley Wealth Advisors Inc.

B. Riley Wealth Advisors Inc. trimmed its position in Danaher Co. (NYSE:DHR) by 9.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,002 shares of the conglomerate’s stock after selling 1,033 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Danaher were worth $2,773,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. FMR LLC raised its stake in Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after acquiring an additional 3,217,631 shares in the last quarter. TD Asset Management Inc raised its stake in Danaher by 99.0% during the 2nd quarter. TD Asset Management Inc now owns 1,358,706 shares of the conglomerate’s stock worth $339,473,000 after acquiring an additional 675,952 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in Danaher by 22.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate’s stock worth $761,475,000 after acquiring an additional 563,546 shares in the last quarter. International Assets Investment Management LLC raised its stake in Danaher by 40,196.5% during the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after acquiring an additional 428,897 shares in the last quarter. Finally, Montrusco Bolton Investments Inc. raised its stake in Danaher by 30.4% during the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after acquiring an additional 397,671 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Up 0.2 %

Shares of NYSE:DHR opened at $234.89 on Monday. The company has a market cap of $169.66 billion, a price-to-earnings ratio of 44.83, a PEG ratio of 4.33 and a beta of 0.83. The firm’s 50-day simple moving average is $246.92 and its 200-day simple moving average is $257.43. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the previous year, the firm earned $2.02 earnings per share. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. As a group, equities research analysts predict that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is 20.61%.

Analyst Ratings Changes

Several equities research analysts recently commented on DHR shares. Wells Fargo & Company started coverage on shares of Danaher in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price target on the stock. Royal Bank of Canada lowered their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective on the stock in a research report on Friday. Finally, Stephens reissued an “overweight” rating and set a $315.00 price objective on shares of Danaher in a research report on Wednesday, October 23rd. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $287.95.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.